"10.1371_journal.pone.0090141","plos one","2014-02-25T00:00:00Z","Henrica M J Werner; Jone Trovik; Mari K Halle; Elisabeth Wik; Lars A Akslen; Even Birkeland; Therese Bredholt; Ingvild L Tangen; Camilla Krakstad; Helga B Salvesen","Centre for Cancer Biomarkers, Department of Clinical Science, The University of Bergen, Bergen, Norway; Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway; Centre for Cancer Biomarkers, Department of Clinical Medicine, The University of Bergen, Bergen, Norway; Department of Pathology, Haukeland University Hospital, Bergen, Norway","Conceived and designed the experiments: HMJW JT CK HBS. Performed the experiments: HMJW JT ILT EW EB TB MKH CK. Analyzed the data: HMJW JT EW MKH TB CK HBS. Contributed reagents/materials/analysis tools: HBS LAA EB CK, EW. Wrote the paper: HMJW CK JT HBS ILT EW EB TB MKH LAA.","The authors report the following conflicts: The University of Bergen/Haukeland University Hospital/Dana Farber Cancer Institute/Harvard through BTO (Bergen Teknologioverf√∏ring AS): Some aspects relating to STMN1 as prognostic and predictive marker for endometrial cancer are subject to pending intellectual property rights (US 12/962,946). This does not alter the authors' adherence to the PLOS ONE policies on sharing data and materials.","2014","02","Henrica M J Werner","HMJW",10,TRUE,4,8,7,10,TRUE,TRUE,FALSE,0,NA,FALSE
